PURPOSE: The purpose of this study was to develop a nomogram capable of predicting the probability of 5-year survival after radical radiotherapy (RT) without chemotherapy for uterine cervical cancer. METHODS AND MATERIALS: We retrospectively analyzed 549 patients that underwent radical RT for uterine cervical cancer between March 1994 and April 2002 at our institution. Multivariate analysis using Cox proportional hazards regression was performed and this Cox model was used as the basis for the devised nomogram. The model was internally validated for discrimination and calibration by bootstrap resampling. RESULTS: By multivariate regression analysis, the model showed that age, hemoglobin level before RT, Fédération Internationale de Gynécologie Obstétrique (FIGO) stage, maximal tumor diameter, lymph node status, and RT dose at Point A significantly predicted overall survival. The survival prediction model demonstrated good calibration and discrimination. The bootstrap-corrected concordance index was 0.67. The predictive ability of the nomogram proved to be superior to FIGO stage (p=0.01). CONCLUSIONS: The devised nomogram offers a significantly better level of discrimination than the FIGO staging system. In particular, it improves predictions of survival probability and could be useful for counseling patients, choosing treatment modalities and schedules, and designing clinical trials. However, before this nomogram is used clinically, it should be externally validated.
PURPOSE: The purpose of this study was to develop a nomogram capable of predicting the probability of 5-year survival after radical radiotherapy (RT) without chemotherapy for uterine cervical cancer. METHODS AND MATERIALS: We retrospectively analyzed 549 patients that underwent radical RT for uterine cervical cancer between March 1994 and April 2002 at our institution. Multivariate analysis using Cox proportional hazards regression was performed and this Cox model was used as the basis for the devised nomogram. The model was internally validated for discrimination and calibration by bootstrap resampling. RESULTS: By multivariate regression analysis, the model showed that age, hemoglobin level before RT, Fédération Internationale de Gynécologie Obstétrique (FIGO) stage, maximal tumor diameter, lymph node status, and RT dose at Point A significantly predicted overall survival. The survival prediction model demonstrated good calibration and discrimination. The bootstrap-corrected concordance index was 0.67. The predictive ability of the nomogram proved to be superior to FIGO stage (p=0.01). CONCLUSIONS: The devised nomogram offers a significantly better level of discrimination than the FIGO staging system. In particular, it improves predictions of survival probability and could be useful for counseling patients, choosing treatment modalities and schedules, and designing clinical trials. However, before this nomogram is used clinically, it should be externally validated.
Authors: Elizabeth A Kidd; Issam El Naqa; Barry A Siegel; Farrokh Dehdashti; Perry W Grigsby Journal: Gynecol Oncol Date: 2012-06-24 Impact factor: 5.482
Authors: Min Sun Kyung; Hong Bae Kim; Jung Yeob Seoung; In Young Choi; Young Soo Joo; Me Yeon Lee; Jung Bae Kang; Young Han Park Journal: Oncol Lett Date: 2015-03-05 Impact factor: 2.967
Authors: David Lora; Agustín Gómez de la Cámara; Sara Pedraza Fernández; Rafael Enríquez de Salamanca; José Fermín Pérez Regadera Gómez Journal: J Gynecol Oncol Date: 2017-05-26 Impact factor: 4.401
Authors: Won Sup Yoon; Dae Sik Yang; Jung Ae Lee; Nam Kwon Lee; Young Je Park; Chul Yong Kim; Nak Woo Lee; Jin Hwa Hong; Jae Kwan Lee; Jae Yun Song Journal: Biomed Res Int Date: 2017-04-27 Impact factor: 3.411
Authors: Theodora A Koulis; Elizabeth N Kornaga; Robyn Banerjee; Tien Phan; Prafull Ghatage; Anthony M Magliocco; Susan P Lees-Miller; Corinne M Doll Journal: Clin Transl Radiat Oncol Date: 2017-06-12